2018-2023 Global Transplant Diagnostics Consumption Market Report
![](/report_cover/10189/2018-2023-global-transplant-diagnostics-consumption-market-report_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transplant Diagnostics market for 2018-2023.
The demand of transplant diagnostics is increasing repuily.
Over the next five years, LPI(LP Information) projects that Transplant Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Transplant Diagnostics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transplant Diagnostics market for 2018-2023.
The demand of transplant diagnostics is increasing repuily.
Over the next five years, LPI(LP Information) projects that Transplant Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Transplant Diagnostics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Solid Organ Transplantation
- Stem Cell Transplantation
- Soft Tissue Transplantation
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Biofortuna
- Biomerieux SA
- Bio-Rad Laboratories
- Caredx
- F. Hoffman-La Roche
- Gendx
- Hologic
- Illumina
- Immucor
- Luminex
- Merck KGaA
- Omixon
- Qiagen
- Thermo Fisher Scientific
Research objectives
- To study and analyze the global Transplant Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Transplant Diagnostics market by identifying its various subsegments.
- Focuses on the key global Transplant Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Transplant Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Transplant Diagnostics submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transplant Diagnostics Consumption 2013-2023
2.1.2 Transplant Diagnostics Consumption CAGR by Region
2.2 Transplant Diagnostics Segment by Type
2.2.1 Solid Organ Transplantation
2.2.2 Stem Cell Transplantation
2.2.3 Soft Tissue Transplantation
2.3 Transplant Diagnostics Consumption by Type
2.3.1 Global Transplant Diagnostics Consumption Market Share by Type (2013-2018)
2.3.2 Global Transplant Diagnostics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Transplant Diagnostics Sale Price by Type (2013-2018)
2.4 Transplant Diagnostics Segment by Application
2.4.1 Independent Reference Laboratories
2.4.2 Hospitals & Transplant Centers
2.4.3 Research Laboratories & Academic Institutes
2.5 Transplant Diagnostics Consumption by Application
2.5.1 Global Transplant Diagnostics Consumption Market Share by Application (2013-2018)
2.5.2 Global Transplant Diagnostics Value and Market Share by Application (2013-2018)
2.5.3 Global Transplant Diagnostics Sale Price by Application (2013-2018)
3 GLOBAL TRANSPLANT DIAGNOSTICS BY PLAYERS
3.1 Global Transplant Diagnostics Sales Market Share by Players
3.1.1 Global Transplant Diagnostics Sales by Players (2016-2018)
3.1.2 Global Transplant Diagnostics Sales Market Share by Players (2016-2018)
3.2 Global Transplant Diagnostics Revenue Market Share by Players
3.2.1 Global Transplant Diagnostics Revenue by Players (2016-2018)
3.2.2 Global Transplant Diagnostics Revenue Market Share by Players (2016-2018)
3.3 Global Transplant Diagnostics Sale Price by Players
3.4 Global Transplant Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Transplant Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Transplant Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 TRANSPLANT DIAGNOSTICS BY REGIONS
4.1 Transplant Diagnostics by Regions
4.1.1 Global Transplant Diagnostics Consumption by Regions
4.1.2 Global Transplant Diagnostics Value by Regions
4.2 Americas Transplant Diagnostics Consumption Growth
4.3 APAC Transplant Diagnostics Consumption Growth
4.4 Europe Transplant Diagnostics Consumption Growth
4.5 Middle East & Africa Transplant Diagnostics Consumption Growth
5 AMERICAS
5.1 Americas Transplant Diagnostics Consumption by Countries
5.1.1 Americas Transplant Diagnostics Consumption by Countries (2013-2018)
5.1.2 Americas Transplant Diagnostics Value by Countries (2013-2018)
5.2 Americas Transplant Diagnostics Consumption by Type
5.3 Americas Transplant Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Transplant Diagnostics Consumption by Countries
6.1.1 APAC Transplant Diagnostics Consumption by Countries (2013-2018)
6.1.2 APAC Transplant Diagnostics Value by Countries (2013-2018)
6.2 APAC Transplant Diagnostics Consumption by Type
6.3 APAC Transplant Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Transplant Diagnostics by Countries
7.1.1 Europe Transplant Diagnostics Consumption by Countries (2013-2018)
7.1.2 Europe Transplant Diagnostics Value by Countries (2013-2018)
7.2 Europe Transplant Diagnostics Consumption by Type
7.3 Europe Transplant Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transplant Diagnostics by Countries
8.1.1 Middle East & Africa Transplant Diagnostics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Transplant Diagnostics Value by Countries (2013-2018)
8.2 Middle East & Africa Transplant Diagnostics Consumption by Type
8.3 Middle East & Africa Transplant Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Transplant Diagnostics Distributors
10.3 Transplant Diagnostics Customer
11 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FORECAST
11.1 Global Transplant Diagnostics Consumption Forecast (2018-2023)
11.2 Global Transplant Diagnostics Forecast by Regions
11.2.1 Global Transplant Diagnostics Forecast by Regions (2018-2023)
11.2.2 Global Transplant Diagnostics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transplant Diagnostics Forecast by Type
11.8 Global Transplant Diagnostics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 BD
12.1.1 Company Details
12.1.2 Transplant Diagnostics Product Offered
12.1.3 BD Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 BD News
12.2 Biofortuna
12.2.1 Company Details
12.2.2 Transplant Diagnostics Product Offered
12.2.3 Biofortuna Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Biofortuna News
12.3 Biomerieux SA
12.3.1 Company Details
12.3.2 Transplant Diagnostics Product Offered
12.3.3 Biomerieux SA Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Biomerieux SA News
12.4 Bio-Rad Laboratories
12.4.1 Company Details
12.4.2 Transplant Diagnostics Product Offered
12.4.3 Bio-Rad Laboratories Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Bio-Rad Laboratories News
12.5 Caredx
12.5.1 Company Details
12.5.2 Transplant Diagnostics Product Offered
12.5.3 Caredx Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Caredx News
12.6 F. Hoffman-La Roche
12.6.1 Company Details
12.6.2 Transplant Diagnostics Product Offered
12.6.3 F. Hoffman-La Roche Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 F. Hoffman-La Roche News
12.7 Gendx
12.7.1 Company Details
12.7.2 Transplant Diagnostics Product Offered
12.7.3 Gendx Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Gendx News
12.8 Hologic
12.8.1 Company Details
12.8.2 Transplant Diagnostics Product Offered
12.8.3 Hologic Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Hologic News
12.9 Illumina
12.9.1 Company Details
12.9.2 Transplant Diagnostics Product Offered
12.9.3 Illumina Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Illumina News
12.10 Immucor
12.10.1 Company Details
12.10.2 Transplant Diagnostics Product Offered
12.10.3 Immucor Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Immucor News
12.11 Luminex
12.12 Merck KGaA
12.13 Omixon
12.14 Qiagen
12.15 Thermo Fisher Scientific
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transplant Diagnostics Consumption 2013-2023
2.1.2 Transplant Diagnostics Consumption CAGR by Region
2.2 Transplant Diagnostics Segment by Type
2.2.1 Solid Organ Transplantation
2.2.2 Stem Cell Transplantation
2.2.3 Soft Tissue Transplantation
2.3 Transplant Diagnostics Consumption by Type
2.3.1 Global Transplant Diagnostics Consumption Market Share by Type (2013-2018)
2.3.2 Global Transplant Diagnostics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Transplant Diagnostics Sale Price by Type (2013-2018)
2.4 Transplant Diagnostics Segment by Application
2.4.1 Independent Reference Laboratories
2.4.2 Hospitals & Transplant Centers
2.4.3 Research Laboratories & Academic Institutes
2.5 Transplant Diagnostics Consumption by Application
2.5.1 Global Transplant Diagnostics Consumption Market Share by Application (2013-2018)
2.5.2 Global Transplant Diagnostics Value and Market Share by Application (2013-2018)
2.5.3 Global Transplant Diagnostics Sale Price by Application (2013-2018)
3 GLOBAL TRANSPLANT DIAGNOSTICS BY PLAYERS
3.1 Global Transplant Diagnostics Sales Market Share by Players
3.1.1 Global Transplant Diagnostics Sales by Players (2016-2018)
3.1.2 Global Transplant Diagnostics Sales Market Share by Players (2016-2018)
3.2 Global Transplant Diagnostics Revenue Market Share by Players
3.2.1 Global Transplant Diagnostics Revenue by Players (2016-2018)
3.2.2 Global Transplant Diagnostics Revenue Market Share by Players (2016-2018)
3.3 Global Transplant Diagnostics Sale Price by Players
3.4 Global Transplant Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Transplant Diagnostics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Transplant Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 TRANSPLANT DIAGNOSTICS BY REGIONS
4.1 Transplant Diagnostics by Regions
4.1.1 Global Transplant Diagnostics Consumption by Regions
4.1.2 Global Transplant Diagnostics Value by Regions
4.2 Americas Transplant Diagnostics Consumption Growth
4.3 APAC Transplant Diagnostics Consumption Growth
4.4 Europe Transplant Diagnostics Consumption Growth
4.5 Middle East & Africa Transplant Diagnostics Consumption Growth
5 AMERICAS
5.1 Americas Transplant Diagnostics Consumption by Countries
5.1.1 Americas Transplant Diagnostics Consumption by Countries (2013-2018)
5.1.2 Americas Transplant Diagnostics Value by Countries (2013-2018)
5.2 Americas Transplant Diagnostics Consumption by Type
5.3 Americas Transplant Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Transplant Diagnostics Consumption by Countries
6.1.1 APAC Transplant Diagnostics Consumption by Countries (2013-2018)
6.1.2 APAC Transplant Diagnostics Value by Countries (2013-2018)
6.2 APAC Transplant Diagnostics Consumption by Type
6.3 APAC Transplant Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Transplant Diagnostics by Countries
7.1.1 Europe Transplant Diagnostics Consumption by Countries (2013-2018)
7.1.2 Europe Transplant Diagnostics Value by Countries (2013-2018)
7.2 Europe Transplant Diagnostics Consumption by Type
7.3 Europe Transplant Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transplant Diagnostics by Countries
8.1.1 Middle East & Africa Transplant Diagnostics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Transplant Diagnostics Value by Countries (2013-2018)
8.2 Middle East & Africa Transplant Diagnostics Consumption by Type
8.3 Middle East & Africa Transplant Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Transplant Diagnostics Distributors
10.3 Transplant Diagnostics Customer
11 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FORECAST
11.1 Global Transplant Diagnostics Consumption Forecast (2018-2023)
11.2 Global Transplant Diagnostics Forecast by Regions
11.2.1 Global Transplant Diagnostics Forecast by Regions (2018-2023)
11.2.2 Global Transplant Diagnostics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transplant Diagnostics Forecast by Type
11.8 Global Transplant Diagnostics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 BD
12.1.1 Company Details
12.1.2 Transplant Diagnostics Product Offered
12.1.3 BD Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 BD News
12.2 Biofortuna
12.2.1 Company Details
12.2.2 Transplant Diagnostics Product Offered
12.2.3 Biofortuna Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Biofortuna News
12.3 Biomerieux SA
12.3.1 Company Details
12.3.2 Transplant Diagnostics Product Offered
12.3.3 Biomerieux SA Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Biomerieux SA News
12.4 Bio-Rad Laboratories
12.4.1 Company Details
12.4.2 Transplant Diagnostics Product Offered
12.4.3 Bio-Rad Laboratories Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Bio-Rad Laboratories News
12.5 Caredx
12.5.1 Company Details
12.5.2 Transplant Diagnostics Product Offered
12.5.3 Caredx Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Caredx News
12.6 F. Hoffman-La Roche
12.6.1 Company Details
12.6.2 Transplant Diagnostics Product Offered
12.6.3 F. Hoffman-La Roche Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 F. Hoffman-La Roche News
12.7 Gendx
12.7.1 Company Details
12.7.2 Transplant Diagnostics Product Offered
12.7.3 Gendx Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Gendx News
12.8 Hologic
12.8.1 Company Details
12.8.2 Transplant Diagnostics Product Offered
12.8.3 Hologic Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Hologic News
12.9 Illumina
12.9.1 Company Details
12.9.2 Transplant Diagnostics Product Offered
12.9.3 Illumina Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Illumina News
12.10 Immucor
12.10.1 Company Details
12.10.2 Transplant Diagnostics Product Offered
12.10.3 Immucor Transplant Diagnostics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Immucor News
12.11 Luminex
12.12 Merck KGaA
12.13 Omixon
12.14 Qiagen
12.15 Thermo Fisher Scientific
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Transplant Diagnostics
Table Product Specifications of Transplant Diagnostics
Figure Transplant Diagnostics Report Years Considered
Figure Market Research Methodology
Figure Gl
Figure Picture of Transplant Diagnostics
Table Product Specifications of Transplant Diagnostics
Figure Transplant Diagnostics Report Years Considered
Figure Market Research Methodology
Figure Gl